DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways
暂无分享,去创建一个
Yu-qin Pan | Bangshun He | Shukui Wang | Bei Pan | Xiangxiang Liu | Huiling Sun | Mu Xu | Xiaoxiang Chen | Xueni Xu | K. Zeng | Xiuxiu Hu | Tao Xu
[1] Liang Wu,et al. MicroRNA-664 Targets Insulin Receptor Substrate 1 to Suppress Cell Proliferation and Invasion in Breast Cancer. , 2019, Oncology research.
[2] V. Costa,et al. The Multifaceted Role of Annexin A1 in Viral Infections , 2023, Cells.
[3] Lihua Jiang,et al. MicroRNA-623 Targets Cyclin D1 to Inhibit Cell Proliferation and Enhance the Chemosensitivity of Cells to 5-Fluorouracil in Gastric Cancer. , 2018, Oncology research.
[4] Kai Yuan,et al. miR-486-5p functions as an oncogene by targeting PTEN in non-small cell lung cancer. , 2018, Pathology, research and practice.
[5] Chunxing Yang,et al. Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3′-untranslated region in colorectal cancer , 2018, International journal of oncology.
[6] W. Zhai,et al. DNA‐methylation‐mediated repression of miR‐766‐3p promotes cell proliferation via targeting SF2 expression in renal cell carcinoma , 2017, International journal of cancer.
[7] Yang Yang,et al. The miR-486-5p plays a causative role in prostate cancer through negative regulation of multiple tumor suppressor pathways , 2017, Oncotarget.
[8] G. Qing,et al. Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism , 2017, Oncogenesis.
[9] Zengfang Wang,et al. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer , 2017, Oncotarget.
[10] Yusuke Nakamura,et al. miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer , 2017, Oncology letters.
[11] Zhi Zhu,et al. Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma , 2017, Oncology reports.
[12] X. Yu,et al. Downregulated miR-486-5p acts as a tumor suppressor in esophageal squamous cell carcinoma. , 2016, Experimental and therapeutic medicine.
[13] A. Weisz,et al. The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. , 2016, Cell reports.
[14] Liang Zhao,et al. Epigenetic silencing of miR-490-3p promotes development of an aggressive colorectal cancer phenotype through activation of the Wnt/β-catenin signaling pathway. , 2016, Cancer letters.
[15] Ning Shi,et al. miR-486-5p attenuates tumor growth and lymphangiogenesis by targeting neuropilin-2 in colorectal carcinoma , 2016, OncoTargets and therapy.
[16] Li Zhang,et al. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[17] Jiwei Sun,et al. RETRACTED ARTICLE: MiR-200 suppresses metastases of colorectal cancer through ZEB1 , 2016, Tumor Biology.
[18] Thomas Bonfert,et al. p53-Regulated Networks of Protein, mRNA, miRNA, and lncRNA Expression Revealed by Integrated Pulsed Stable Isotope Labeling With Amino Acids in Cell Culture (pSILAC) and Next Generation Sequencing (NGS) Analyses* , 2015, Molecular & Cellular Proteomics.
[19] H. Brody. Colorectal cancer , 2015, Nature.
[20] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[21] Guihua Sun,et al. MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors. , 2015, Blood.
[22] Hong Yuan,et al. PLAGL2 regulates actin cytoskeletal architecture and cell migration. , 2014, Carcinogenesis.
[23] P. Gao,et al. The role of pleomorphic adenoma gene-like 2 in gastrointestinal cancer development, progression, and prognosis. , 2014, International journal of clinical and experimental pathology.
[24] X Wang,et al. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer , 2014, Oncogene.
[25] F. Sánchez‐Madrid,et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs , 2013, Nature Communications.
[26] Jianming Xu,et al. Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] Yanlei Ma,et al. SP1 mediates the link between methylation of the tumour suppressor miR‐149 and outcome in colorectal cancer , 2013, The Journal of pathology.
[28] Meng-Chun W. Yang,et al. Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema. , 2011, Lung cancer.
[29] L. Castilla,et al. The PlagL2 transcription factor activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells , 2010, Leukemia.
[30] Yonghong Xiao,et al. PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. , 2010, Cancer cell.
[31] Tracey S. Hanks,et al. Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex. , 2010, Gene.
[32] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[33] B. Wolpin,et al. Systemic treatment of colorectal cancer. , 2008, Gastroenterology.
[34] Yuhong Guo,et al. PLAGL2 translocation and SP-C promoter activity--a cellular response of lung cells to hypoxia. , 2007, Biochemical and biophysical research communications.
[35] Yu-Chung Yang,et al. Sumoylation and Acetylation Play Opposite Roles in the Transactivation of PLAG1 and PLAGL2* , 2005, Journal of Biological Chemistry.
[36] Ruud Delwel,et al. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. , 2005, Blood.
[37] Eugene Berezikov,et al. Phylogenetic Shadowing and Computational Identification of Human microRNA Genes , 2005, Cell.
[38] O. Kronborg,et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds , 2004, Scandinavian journal of gastroenterology.
[39] W. V. D. Van de Ven,et al. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. , 2002, Cancer research.
[40] Taiho Kambe,et al. Involvement of PLAGL2 in activation of iron deficient- and hypoxia-induced gene expression in mouse cell lines , 2001, Oncogene.
[41] J. Hardcastle,et al. Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.